- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05045911
An Endoscopic Barbed-clips Suturing for Colorectal ESD
September 14, 2021 updated by: Affiliated Hospital to Academy of Military Medical Sciences
A Novel Endoscopic Barbed-clips Suturing for Mucosal Defect Closure After Endoscopic Submucosal Dissection of Colon
Endoscopic submucosal dissection (ESD) was developed to allow en bloc resection of colorectal neoplasm.
Although colorectal ESD has been widely accepted as a minimally invasive treatment option for early colorectal neoplasm, post-ESD bleeding is one of the major adverse events.
After ESD procedure, endoscopists close the defects with devices to prevent complications.
A novel endoscopic barbed-clips suturing has been developed to simplify endoscopic closure.
In this study, the endoscopic barbed-clips will be evaluated when closing defects in the colon after ESD.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Endoscopic submucosal dissection (ESD) has emerged as a new endoscopic technique that allows en-bloc resection of GI lesions, irrespective of size.
The most common complications of the ESD techniques are bleeding and perforation.
Several reports have shown that if prophylactic closure of a mucosal defect with clips would reduce the risk of bleeding following endoscopic intervention by ESD.
With the advancements in endoscopic therapy, various techniques for prevention of post-ESD complications have been reported.
However, there have some limitations including their inability to close large defects and the complexity of the approaches and the need for expensive equipment to complete the procedure.
To address these issues, we have devised a novel endoscopic barbed-clips suturing method for mucosal defect closure after endoscopic submucosal dissection of colon.
In this study, we assessed the technical feasibility of this novel technique.
Study Type
Interventional
Enrollment (Anticipated)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yiliang Bi, Dr.
- Phone Number: +8613240439961
- Email: yiliangbi@163.com
Study Contact Backup
- Name: Pei Deng, Dr.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100853
- Recruiting
- The First Medical Center of Chinese PLA General Hospital
-
Contact:
- Yan Liu
- Phone Number: +8613911798288
- Email: 13911798288@163.com
-
Principal Investigator:
- Yan Liu
-
Beijing, Beijing, China, 100071
- Recruiting
- The Fifth Medical Center of Chinese PLA General Hospital
-
Contact:
- Min Min, Dr.
- Phone Number: +8613426165452
- Email: minmin823@sina.com
-
Principal Investigator:
- Yan Liu, Pro.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- aged≥20 years with a single clinically or histologically diagnosed colorectal lesions of 20-50mm eligible for which fulfilled criteria for ESD;
Exclusion Criteria:
- Patients with coagulopathy (platelet count < 5 × 10*4, prothrombin time international normalized ratio > 2,
- medical conditions requiring the continuous use of antithrombotic agents
- prior abdominal surgery or radiation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Endoscopic Barbed-clips Suturing
Patients will be closed the mucosal defect after colorectal ESD using Endoscopic Barbed-clips Suturing.
|
Endoscopic Barbed-clips Suturing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The technical success rate
Time Frame: 1 day
|
Rate of completely closure of the ESD defect
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Endoscopic barbed-clips suturing closure time
Time Frame: 1 day
|
The time required to close the defect using endoscopic barbed-clips suturing
|
1 day
|
|
Rate of patients reported with bleeding/perforation post-ESD procedure
Time Frame: 7 days
|
Conduct follow-ups for risk of bleeding and perforation after closure
|
7 days
|
|
Clips used post-ESD
Time Frame: 7 days
|
Record number of clips needed to close lesion
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 20, 2021
Primary Completion (Anticipated)
December 1, 2021
Study Completion (Anticipated)
December 20, 2021
Study Registration Dates
First Submitted
August 17, 2021
First Submitted That Met QC Criteria
September 14, 2021
First Posted (Actual)
September 16, 2021
Study Record Updates
Last Update Posted (Actual)
September 16, 2021
Last Update Submitted That Met QC Criteria
September 14, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Endo-barbed clips suturing
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Neoplasms
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...CompletedColorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal CancerUnited States
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Neoplasms Malignant | Colorectal Cancer Stage IUnited States, Japan, Italy, Spain
-
NuCana plcCompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States, France, United Kingdom
-
The Queen Elizabeth HospitalNovartis; AmgenCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalAustralia
-
Novartis PharmaceuticalsCompletedColorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States
-
ProgenaBiomeWithdrawnColorectal Neoplasms | Colorectal Cancer | Colorectal Cancer Metastatic | Colorectal Carcinoma | Colorectal Adenocarcinoma | Colorectal SarcomaUnited States
-
University of ChicagoVerastem, Inc.SuspendedColorectal Cancer | Colorectal Cancer Metastatic | Colorectal Adenocarcinoma | Advanced Colorectal Carcinoma | Advanced Colorectal AdenocarcinomaUnited States
-
Bristol-Myers SquibbNovartisCompletedColorectal Cancer | Colorectal Neoplasm | Colorectal Tumors | Colorectal CarcinomaUnited States, Canada, Spain, Argentina, Australia, Belgium, Czechia, Italy, Chile, Germany
-
City of Hope Medical CenterRecruitingColorectal Neoplasms | Colorectal Cancer | Colorectal Disorders | Colorectal Adenocarcinoma | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Polyp | Colorectal Neoplasms Malignant | Colorectal Adenomatous Polyp | Colorectal Cancer Stage I | Colorectal Adenoma... and other conditionsUnited States, Italy, China, Spain, Japan
-
Pawel KalinskiNational Cancer Institute (NCI)CompletedColorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, ColorectalUnited States
Clinical Trials on Endoscopic Barbed-clips Suturing
-
NYU Langone HealthWithdrawn
-
First Hospital of China Medical UniversityCompletedGastric Submucosal Tumors | Endoscopic Full Thickness Resection (EFTR)China
-
Institute for Clinical and Experimental MedicineCompleted
-
Jagiellonian UniversityCompletedEndoscopic Surgical ProceduresPoland
-
Duke UniversityCompleted
-
Jagiellonian UniversityCompletedEndoscopic Surgical ProceduresPoland
-
University of California, San FranciscoWithdrawnWeight Loss | Morbid Obesity | Complex Incisional HerniasUnited States
-
Liu YanEnrolling by invitation
-
Brigham and Women's HospitalApollo Endosurgery, Inc.CompletedObesity | Overweight | Body WeightUnited States
-
Istituto Auxologico ItalianoRecruiting